Literature DB >> 33037133

Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures.

Gerhard Liebisch1, Eoin Fahy2, Junken Aoki3, Edward A Dennis4, Thierry Durand5, Christer S Ejsing6, Maria Fedorova7, Ivo Feussner8, William J Griffiths9, Harald Köfeler10, Alfred H Merrill11, Robert C Murphy12, Valerie B O'Donnell13, Olga Oskolkova14, Shankar Subramaniam15, Michael J O Wakelam16, Friedrich Spener17.   

Abstract

A comprehensive and standardized system to report class="Chemical">lipid structures analyzed by MS is essential for the communication and storage of <class="Chemical">span class="Chemical">lipidomics data. Herein, an update on both the LIPID MAPS classification system and shorthand notation of lipid structures is presented for lipid categories Fatty Acyls (FA), Glycerolipids (GL), Glycerophospholipids (GP), Sphingolipids (SP), and Sterols (ST). With its major changes, i.e., annotation of ring double bond equivalents and number of oxygens, the updated shorthand notation facilitates reporting of newly delineated oxygenated lipid species as well. For standardized reporting in lipidomics, the hierarchical architecture of shorthand notation reflects the diverse structural resolution powers provided by mass spectrometric assays. Moreover, shorthand notation is expanded beyond mammalian phyla to lipids from plant and yeast phyla. Finally, annotation of atoms is included for the use of stable isotope-labeled compounds in metabolic labeling experiments or as internal standards. This update on lipid classification, nomenclature, and shorthand annotation for lipid mass spectra is considered a standard for lipid data presentation.
Copyright © 2020 Liebisch et al. Published by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  fatty acyls; glycerolipids; glycerophospholipids; lipidomics; mass spectrometry; sphingolipids; sterols

Year:  2020        PMID: 33037133      PMCID: PMC7707175          DOI: 10.1194/jlr.S120001025

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


class="Chemical">Lipids have become increasin<class="Chemical">span class="Chemical">gly recognized as the central metabolites affecting human physiology and pathophysiology, and LIPID MAPS has recently expanded its tools, resources, data, and training as a free resource dedicated to serving the lipid research community (1). Following development of the LIPID MAPS nomenclature, classification, and structural representation system (2, 3), an initial shorthand nomenclature was proposed (4), which included a structural hierarchy as shown by others as well (5, 6). These were the first attempts to provide rules for reporting mass spectrometric data dependent on the power for structural resolution of lipids by the instrumental set-ups in use at that time. Today, we recognize that the field has evolved in often diverging ways and that this has not enabled a unifying naming convention to be adopted throughout. For example, alternative shorthand notation has evolved for some class="Chemical">lipid classes, a plethora of newly determined structures for <class="Chemical">span class="Chemical">lipids from various classes and phylogenetic kingdoms (higher plants and yeasts) have been described, and progress in the technological development of mass spectrometers with greater structural resolution as well as advances in automation in interpreting high-throughput data has occurred. To address this, it is the aim of this report to take into account these developments and to present an update on the LIPID MAPS classification and a pragmatic highly usable shorthand notation for those active in lipid research. This update will focus on five of the eight LIPID MAPS categories (2), namely Fatty Acyls (FA), Glycerolipids (GL), Glycerophospholipids (GP), Sphingolipids (SP), and Sterols (ST). Annotation is modified to permit annotation of oxygenated lipids and examples will be given for lipid classes occurring outside the mammalian kingdom. “Biological intelligence” has been considered as topical knowledge about a class="Chemical">lipid molecule, such as its structural building blocks, enzymatic pathways for generation and metabolism, and biological functions (4). Interpretation by biological evidence in shorthand notation can be useful when mass class="Chemical">spectra contain structural ambiguities or lack of clear structural evidence. Consequently, annotations with the help of biological evidence contain assumptions, and it must be recognized and recorded that this may lead to misinterpretations. Moreover, in the pragmatic approach presented in this work, we will make more use of common and/or <class="Chemical">span class="Chemical">trivial names for the shorthand notation. For example, the structures of sterols, prostaglandins, resolvins, etc. have been characterized by chemical and spectroscopic methods, including stereochemistry, and common names exist, as do shorthand notations in many cases. Their mass spectra are also known; however, their stereochemistry and isomerism and other structural information often cannot be deduced directly from the spectra when these lipids are measured in biological samples. Assignment of a common name or of shorthand notation to such chromatographic and MS/MS data is permissible, but it may be based on annotation that includes biological intelligence, and that needs to be clearly stated as well. In any case, assumptions made should be sclass="Chemical">triking a unique <class="Chemical">span class="Chemical">balance between what we think we know about structure and function of a lipid molecule and what a specific MS-based analytical method definitively informs us about the lipid structure.

UPDATE ON NOMENCLATURE AND CLASSIFICATION

Modification of class="Chemical">Fatty Acyls by <class="Chemical">span class="Chemical">oxygen, either catalyzed enzymatically or by means of radical chemistry, is an important focus in biomedical research, due to the impressive biological activities of products thus obtained. Based on these two mechanisms, all compounds originating from polyunsaturated fatty acyls (PUFAs) having methylene-interrupted cis-double bonds (DBs) (also chemically referred to as allylic DBs) and being enzymatically or nonenzymatically oxygenated are grouped within the appropriate class in the Fatty Acyl category. Historically, the term “eicosanoid” has included “related oxygenated polyunsaturated fatty acids” with shorter or longer chain lengths, but in the LIPID MAPS classification, compounds are strictly assigned to a class based on their chain length (e.g., octadecanoids, eicosanoids, docosanoids). Recently, the common name “oxylipins”, standing for “oxygenated fatty acyls”, has come into widespread use. Similarly, in the Glycerophospholipids (GP) category, many newly described phospholipids contain oxygenated fatty acyls (or oxylipins) often termed “oxygenated phospholipids” (OxPLs). Those are produced by oxygenation of constituent fatty acyls enzymatically and nonenzymatically, or by chemical modification of polar head groups containing an amino function (PE and PS), i.e., N-modified phospholipids. In the following, we elaborate first on experimental prerequisites for correct annotation of class="Chemical">lipid mass class="Chemical">spectrome<class="Chemical">span class="Chemical">tric data and, second, present the updates on rules for using shorthand notation. Finally, in order of categories, we present mostly in the form of easily readable tables, all updates on lipid nomenclature and classification including respective shorthand abbreviations according to the LIPID MAPS web resources and the updated shorthand notation for lipid species and lipid molecular species. To further enhance the understanding of shorthand notation, some chemical structures are presented in the tables. The updated shorthand notation schemes described herein have been incorporated into a number of key resources on the LIPID MAPS website, notably the LIPID MAPS Structure Database (LMSD) and the MS search tools (see the Hierarchical concept and application of shorthand notation section below), by generating level-specific abbreviations (e.g., sum-composition and chain-specific annotations) for lipid structures. This approach is important in terms of the development of MS search databases that are appropriate for the technique used (sum-composition databases for precursor ion data and chain-composition databases for MS/MS data).

EXPERIMENTAL PREREQUISITES FOR CORRECT ANNOTATION

All <span class="Chemical">lipid class="Chemical">species and <class="Chemical">span class="Chemical">lipid molecular species data presented need information on levels of structural resolution attained by mass spectrometric analysis, and sufficient supplementary data to justify annotation by shorthand notation. At minimum, such data should contain the measured intact m/z value, the adduct ion used for identification, the retention time when chromatography is applied, and the measured fragment m/z values. Assignment and therefore use of specific shorthand nomenclature for defined functional groups () requires additional techniques. An example is derivatization of class="Chemical">hydroxyl groups by <class="Chemical">span class="Chemical">trimethylsilylation followed by GC/MS EI and analysis of fragment ions formed. In many cases ESI-MS/MS of underivatized constituent fatty acyls in general leads to specific product ions, if ESI populates a charge site near the functional group (7). Definition of DB positions can be determined by several techniques including ozonolysis during analysis (OzID) (8) or specific adduct formation with acetone in photochemical Paterno-Büchi reaction (9). These reactions can be carried out in shotgun or LC-MS/MS experiments. High energy MS/MS has been used to assign DB position of fairly complex fatty acyls as well as methyl branching (10). Alternatively, GC/MS can be used including specific derivatization of the carboxylate group, to drive specific DB fragmentation in EI spectra (11). Chemical ionization techniques are also useful by application of specific chemical ionization reagent gases to define DB positions (12). Abbreviations of functional groups/side chains The order of functional groups aligns with IUPAC hierarchy (14). Abbreviations of cyclic structures Abbreviations of <span class="Chemical">carbohydrate structures class="Chemical">Glycan annotation is <class="Chemical">span class="Chemical">based on IUPAC-approved abbreviations (https://www.ncbi.nlm.nih.gov/glycans/snfg.html) (15). Common names of class="Chemical">lipid class="Chemical">species, e.g., for certain <class="Chemical">span class="Chemical">fatty acids and for oxygenated fatty acids denote a chemically defined structure including stereochemistry. For proper annotations in these cases, the analytical method has to provide for chiral separation of known stereoisomeric compounds. This validation demands data on reproducibility and limit of quantification. Similarly, when novel structures are described, analytical details proving structural details need to accompany the data. Guidelines for method validation and reporting of novel lipid molecules are currently being developed within the Lipidomics Standard Initiative (https://lipidomics-standards-initiative.org) as community-wide effort (13).

UPDATES ON GENERAL RULES FOR SHORTHAND NOTATION

Here, we describe updates and rules applicable to all class="Chemical">lipid categories described below. This includes rules on the hierarchical concept and application of the nomenclature and annotation of <class="Chemical">span class="Chemical">lipid structures as well as on annotation of stable isotope-labeled lipids. Three major updates are: The term “DBs” is replaced by “double bond equivalents” (class="Chemical">DBEs), because removal of two <class="Chemical">span class="Chemical">hydrogen atoms from precursor lipid forms a double bond, an oxo group or a cyclic structure. Frequently, MS does not distinguish between these alternatives. class="Chemical">Oxygen atoms represent not only the main component introduced during <class="Chemical">span class="Chemical">oxygenation, but occurs also in hydroxy groups as a principal structural feature in many lipid classes such as sphingoid bases. Because hydroxy, oxo or other oxygen functional groups may not be differentiated by high resolution/accurate mass analysis, annotation is done by the number of oxygens linked to the hydrocarbon chain. Use of parentheses and brackets is minimized. Parentheses indicate primarily positions and, with regard to functional groups only those with numbers behind them, like class="Chemical">(OH)2, (NO2), (NH2). The use of square brackets is res<class="Chemical">span class="Chemical">tricted to chemical configurations R and S, to stable isotopes, and to the frame of carbons in a ring structure.

Hierarchical concept and application of shorthand notation

Upon application of a validated MS-method, interpretation of mass spectra by “biological intelligence” and the use of common or <span class="Chemical">trivial names, as alluded to class="Chemical">specifically in the introduction, is permissible. Such annotations need to be clearly stated. Examples are ambiguities pertaining to bond type, <class="Chemical">span class="Chemical">oxygenated groups, and branched chains. class="Chemical">Species level” is now the lowest hierarchical level. It represents the sum composition, i.e., sum of <class="Chemical">span class="Chemical">carbon atoms, DBEs, and number of additional oxygen atoms, e.g., FA 18:1;O. It thus replaces former “Lipid class level” mass (i.e., lipid class and the – uncharged - molecular mass). Of note, for sterols, the ABCD ring system is assumed and not expressed as DBE. class="Chemical">Phosphate-position level” annotates positions of <class="Chemical">span class="Chemical">phosphate group(s), e.g., PIP(3′) or PIP2(4′,5′) at phosphatidylinositolphosphate. “Molecular species level” pertains to all categories addressed here and is reached as soon as constituent fatty acyl/alkyl-residues are identified, e.g., TG 16:0_18:1_18:1, a <span class="Chemical">tri<class="Chemical">span class="Chemical">glyceride. “sn-position level” is a more refined level in class="Chemical">GL and <class="Chemical">span class="Chemical">GP categories, enabling annotation of the sn-position of fatty acyl/alkyl constituents at the glycerol backbone as indicated by a slash, e.g., TG 16:0/18:1/18:1. DB-position level” or “<span class="Chemical">DBE-position level” pertain to class="Chemical">species having constituents with defined position of double bonds or double bond equivalents, e.g., FA 18:2 (9, 11);O. Structure defined level” annotates molecular species composed of various constituents and functional groups, yet without positions and stereochemical details, e.g., FA 18:2;OH. “Full structure level” annotates molecular species composed of various constituents and functional groups including positions, yet without stereochemical details, e.g., FA 18:2(9Z,11E);<span class="Chemical">13OH. Complete structure level” defines detailed structures of all functional groups including stereochemistry as shown in the LMSD, e.g., <span class="Chemical">13R-HODE, <class="Chemical">span class="Chemical">13S-HODE (= common name). presents such a hierarchical scheme, taking the example of <span class="Chemical">glucosylceramide.
Fig. 1.

Hierarchical scheme for the analysis of glucosylceramide. “Analysis” presents MS-data and “Annotation” the respective hierarchical levels with corresponding shorthand annotation. The chemical structure illustrates the Complete Structure level, numbers along the sphingoid base indicate conventional numbering of carbons therein.

Hierarchical scheme for the analysis of class="Chemical">glucosylceramide. “Analysis” presents MS-data and “Annotation” the reclass="Chemical">spective hierarchical levels with correclass="Chemical">sponding shorthand annotation. The chemical structure illustrates the Complete Structure level, numbers along the <class="Chemical">span class="Chemical">sphingoid base indicate conventional numbering of carbons therein. A word of caution is appropriate here: Annotations class="Chemical">based solely on m/z features and on returns from data<class="Chemical">span class="Chemical">base retrieval are frequently incorrect due to over-interpretation of experimental data, i.e., returns of chemically defined lipid molecules at Complete structure level. It is therefore of major importance that database search tools return appropriate annotations based on sum composition, i.e., at Species level and Molecular species level. Such tools are, for example, the LIPID MAPS MS search tools (https://lipidmaps.org/resources/tools/bulk_structure_searches_overview.php) (see also comment in the discussion) or the “ALEX lipid calculator” (http://alex123.info/ALEX123/MS.php).

Annotation of lipid structures

class="Chemical">Lipid class="Chemical">species are annotated by class shorthand abbreviation (see Tables 2A-6A), followed by a class="Chemical">space and <class="Chemical">span class="Disease">C-atoms:DBE, e.g., TG 54:5, or C-atoms:DBE;O-atoms in fatty acyl/alkyl residues, e.g., FA 18:1;O or PC 38:3;O2.
TABLE 2A

Class abbreviations in Category FA

Common NameLipid Class, LIPID MAPSAbbreviation
Fatty acidsFatty acids and conjugates [FA01]FA
Fatty alcoholsFatty alcohols [FA05]FOH
Fatty aldehydesFatty aldehydes [FA06]FAL
Acyl carnitinesFatty acyl carnitines [FA0707]CAR
Acyl CoAsFatty acyl CoAs [FA0705]CoA
N-acyl aminesN-acyl amines [FA0802]NA
N-acyl ethanolaminesN-acyl ethanolamines (endocannabinoids) [FA0804]NAE
N-acyl taurinesN-acyl amines [FA0802]NAT
Wax estersWax monoesters [FA0701]WE
Wax diestersWax diesters [FA0702]WD
FA estolidesFAHFA wax monoesters [FA0701]FA-EST
Variable constituents like class="Chemical">fatty acyls/alkyls are assigned <class="Chemical">span class="Chemical">based on their mass as number of C-atoms and number of DBE (C-atoms:DBE), when experimental proof for DB is provided the annotation is C-atoms:DB. Where applicable, the number of oxygen-atoms is added, separated by a semi-colon, e.g., C-atoms:DBE;O-atoms. DB-position is indicated by a number according to D -nomenclature (geometry unknown) or a number followed by geometry (Z for cis, E for tran<span class="Chemical">s). <class="Chemical">span class="Chemical">Specific techniques are required for determination of DB-position (or geometry) to validly use this level of annotation, e.g., FA 18:2 (9, 12), FA 18:2(9Z,12Z). Positions for all functional groups are stated in front of functional group abbreviation, e.g., FA 20:4;<span class="Chemical">12OH. Generally, all functional groups (see for abbreviationclass="Chemical">s) are separated by a semicolon after the number of <class="Chemical">span class="Chemical">DBE. Functional groups are placed inside a separate pair of parentheses, only if more than one followed by the number of groups, e.g., FA 20:3;(OH)2;oxo. Moreover, functional groups containing numbers such as NO2 or NH2 are generally placed inside a separate pair of parentheses, e.g., FA 18:1;(NO2). The order of functional groups follows the IUPAC hierarchy (14). Except for class="Chemical">DBE/DB-position, proven positions of all other functional groups are stated according to D -nomenclature in front of the functional group abbreviation that are separated by a comma if more than one, e.g., FA 20:3(5Z,13E);<class="Chemical">span class="Chemical">11OH,15OH;9oxo Cyclic structures cyX (X = number of class="Disease">ring atoms, see for abbreviation<class="Chemical">span class="Chemical">s) are presented in front of other functional groups. Their structural details are annotated within a pair of square brackets. Within the square brackets the positions of ring atoms, separated by hyphen, are placed in front of the cyX annotation. Other functional groups are placed after the ring structure of the cyX annotation, e.g., FA 20:2;[8-12cy5;11OH;9oxo];15OH = 8-iso-PGE2 or PGE2. class="Chemical">Carbohydrate structures (), e.g., in complex <class="Chemical">span class="Chemical">glycosphingolipids, are annotated as described for glycans (https://www.ncbi.nlm.nih.gov/glycans) (15). When the sequence of sugars components is known they are shown in this order separated by a hyphen, e.g., Gal-Glc-Cer 18:1;O2/16:0. In case the sequence is unknown the components (followed by their number if more than one) are shown in alphabetic order in front of the respective lipid backbone, e.g., Gal2GlcCer 18:1;O2/16:0. Acyl-linkages (N- and/or O-) are annotated by FA <span class="Disease">C-atoms:<class="Chemical">span class="Chemical">DBE inside a separate pair of parentheses with proven position in front, e.g., Cer 18:1;O2/26:0;26O(FA 18:2). Alkyl-linkages (N- and/or O-) are annotated by class="Disease">C-atoms:<class="Chemical">span class="Chemical">DBE inside a separate pair of parentheses with proven position in front, e.g., FA 18:1(12Z);9O(16:1) for an ether lipid. When functional groups are part of class="Chemical">lipid class abbreviation, e.g., <class="Chemical">span class="Chemical">PIP2 or SPBP, their proven positions are shown inside parentheses, separated by a comma if more than one, e.g., PIP2(4′,5′) 38:4 or SPBP (1) 18:1;O2. Greek letters are transcribed to Latin letters as follows: α to a, β to b, γ to g, δ to d, ω to w. Proven stereochemistry is shown after the respective functional group/side chain in square brackets [R] or [S], e.g., FA 20:4(6Z,8E,10E,14Z);class="Chemical">5OH[S],<class="Chemical">span class="Chemical">12OH[R] = LTB4.

Annotation of isotope-labeled lipids

Isotope-containing class="Chemical">lipid structures are indicated in square brackets annotating the isotope, followed by the number of <class="Chemical">span class="Disease">isotopic atoms, e.g., FA 18:1[13C5].• Multiple isotopes are separated by a comma, e.g., FA 18:1[13C5,D4]. When positions of isotopes are known, they are indicated in a separate pair of parentheses in front of the isotope number, e.g., FA 18:1[(14,15,16,17,18)<span class="Chemical">13C5]. Isotopes in class="Chemical">fatty acyls or alkyls and in <class="Chemical">span class="Chemical">sphingoid bases are indicated in square brackets after the number of DBE, e.g., PC 34:1[D9] or PC O-16:0_18:1[13C5] and in Cer 34:1;O2[13C3], respectively. Isotopes in head groups of these structures are indicated in square brackets after class shorthand abbreviation, e.g., PC[D9] 34:1, TG[13C3] 54:3, SM[D9] 34:1;O2. When positions of isotopes in the <span class="Chemical">lipid are not known, they are indicated in square brackets in front of class shorthand abbreviation, e.g., [D5]PC 34:1, [13C7]TG 54:3.

FATTY ACYLS (FA)

Fatty acyls

Shorthand abbreviations for Fatty Acyl classes are stated in . Class abbreviations in Category FA Table 2B shows that lowest resolution level is class="Chemical">based on m/z values, i.e., annotation at <class="Chemical">span class="Chemical">Species level (low mass resolution MS, e.g., carboxylate anion and oxygen atoms from functional groups). In addition, it is assumed that only a straight-chain fatty acid with or without DBE(s) is present. High mass resolution with accurate mass measurements may identify additional elements such as oxygen atoms of functional groups. Thus, a limited amount of structural information is provided at this level of analysis following the rules alluded to in the Annotation of lipid structures section, i.e., Species level. Annotation at DB-position level requires techniques such as ozonolysis (8) or photochemical derivatization (9) or GC-MS. The use of trivial or common names for even simple fatty acids implies that additional methods have been used to define the exact structure, such as a straight-chain, positions of DBs, or DB geometries. Chiral chromatography preceding MS/MS is required for respective stereochemistry. Because this is generally not routinely done, investigators should note in their reports when using a common name for a fatty acid that “The identity and stereochemistry of the fatty acid species reported using a common name (e.g., oleic acid, linolenic acid, arachidonic acid, etc.) is assumed based on biological intelligence”. This comment applies to simple as well as complex lipids that include fatty acids as part of the structure (e.g., glycerophospholipids, triacylglycerols, etc.). Examples for shorthand notation of fatty acids are presented in Table 2B.
TABLE 2B

Level-dependent shorthand notation for examples of fatty acids

SubclassSpecies Levela,bDB-Position LevelcFull Structure LeveldComplete Structure Level (= Common Name)e
Straight-chain FAFA 12:0Laurate
FA 14:0Myristate
FA 16:0Palmitate
FA 16:1FA 16:1(9)FA 16:1(9Z)Palmitoleate
FA 18:0Stearate
FA 18:1FA 18:1(9)FA 18:1(9Z)Oleate
FA 18:1FA 18:1(11)FA 18:1(11E)trans-Vaccenate
FA 18:2FA 18:2(9, 12)FA 18:2(9Z,12Z)Linoleate
FA 18:3FA 18:3(9, 12, 15)FA 18:3(9Z,12Z,15Z)α-Linolenate
FA 18:3FA 18:3(6, 9, 12)FA 18:3(6Z,9Z,12Z)γ-Linolenate
FA 18:4FA 18:4(6, 9, 12, 15)FA 18:4(6Z,9Z,12Z,15Z)Stearidonate
FA 20:0Arachidate
FA 20:3FA 20:3(8, 11, 14)FA 20:3(8Z,11Z,14Z)dihomo-γ-Linolenate
FA 20:3FA 20:3(11, 14, 17)FA 20:3(11Z,14Z,17Z)
FA 20:3FA 20:3(5, 8, 11)FA 20:3(5Z,8Z,11Z)Mead acid
FA 20:4FA 20:4(5, 8, 11, 14)FA 20:4(5Z,8Z,11Z,14Z)Arachidonate
FA 20:5FA 20:5(5, 8, 11, 14, 17)FA 20:5(5Z,8Z,11Z,14Z,17Z)Eicosapentaenoate
FA 22:0Behenate
FA 22:6FA 22:6(4, 7, 10, 13, 16, 19)FA 22:6(4Z,7Z,10Z,13Z,16Z,19Z)Docosahexaenoate
FA 24:0Lignocerate
FA 24:1FA 24:1(15)FA 24:1(15Z)Nervonate
FA 32:5FA 32:5(14, 17, 20, 23, 26)FA 32:5(14Z,17Z,20Z,23Z,26Z)Dotriacontapentaenoic acid; FA 32:5(n-6)
FA 34:5FA 34:5 (19, 22, 25, 28, 31)FA 34:5(19Z,22Z,25Z,28Z,31Z)Tetratriacontapentaenoic acid; FA 34:5(n-3)
FA 36:6FA 36:6(18, 21, 24, 27, 30, 33)FA 36:6(18Z,21Z,24Z,27Z,30Z,33Z)Hexatriacontahexaenoic acid; FA 36:6(n-3)
Fatty acyl esterFA 19:0FA 18:0;1OMeMethyl stearate
Methyl branchedFA 20:0FA 16:0;3Me,7Me,11Me,15MeFA 16:0;3Me,7Me[R],11Me[R],15Me (Phytanate)
HydroxyFA 18:0;OFA 18:0;9OHFA 18:0;9OH[S]
OxoFA 11:1;ObFA 11:0;9oxoFA 11:0;9oxo
CyclopropaneFA 19:1FA 19:0;[11-13cy3:0]Lactobacillic acid
CyclopropeneFA 19:2FA 19:0;[9-11cy3:1(9)]Sterculic acid
CyclopenteneFA 18:3FA 18:1(6Z);[14-18cy5:1(15)]Gorlic acid

Uncharged molecular mass measured by low resolution MS of corresponding m/z from carboxylate anion (electrospray ionization) or molecular ion species (radical cation by EI).

Annotation based on the assumption of a straight-chain fatty acyl plus functional groups based on exact mass measurements using a high-resolution mass spectrometer of fatty acyl indicating ion.

Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).

Shorthand notation applies only when exact location and nature of functional group(s) are determined by specific fragment ions obtained by derivatization and GC/MS or specific product ions in a MS/MS experiment.

Validated assay is required to employ trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic based separation of potential isomers (GC or HPLC).

Level-dependent shorthand notation for examples of <span class="Chemical">fatty acids Uncharged molecular mass measured by low resolution MS of corresponding m/z from <span class="Chemical">carboxylate anion (electroclass="Chemical">spray ionization) or molecular ion class="Chemical">species (radical cation by EI). Annotation <span class="Chemical">based on the assumption of a straight-chain fatty acyl plus functional groups <class="Chemical">span class="Chemical">based on exact mass measurements using a high-resolution mass spectrometer of fatty acyl indicating ion. Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9). Shorthand notation applies only when exact location and nature of functional group(<span class="Chemical">s) are determined by class="Chemical">specific fragment ions obtained by derivatization and GC/MS or class="Chemical">specific product ions in a MS/MS experiment. Validated assay is required to employ <span class="Chemical">trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic <class="Chemical">span class="Chemical">based separation of potential isomers (GC or HPLC). class="Chemical">Fatty acyl esters, i.e., <class="Chemical">span class="Chemical">wax esters (WEs), wax diesters (WDs), fatty acyl estolides (FAHFAs, FA-EST), as well as N-acyl amines (NAs) and N-acyl ethanolamines (NAEs) are shown in Table 2C.
TABLE 2C

Level-dependent shorthand notation for examples of fatty aldehydes, esters, and amides

SubclassSpecies LevelMolecular Species LevelDB-Position LevelaFull Structure LevelbComplete Structure Level (= Common Name)c
Fatty aldehydeFAL 9:1;OFAL 9:1;OFAL 9:1(2);OHFAL 9:1(2E);4OH4-Hydroxynonenal
Wax esterdWE 32:1WE 14:0/18:1WE 14:0/18:1(9)WE 14:0/18:1(9Z)WE 14:0/18:1(9Z)
Alkyl acetatesdWE 20:3WE 18:3/2:0WE 18:3(9,12,15)/2:0WE 18:3(9Z,12Z,15Z)/2:0WE 18:3(9Z,12Z,15Z)/2:0
Wax diesterdWD 42:0WD 22:0/FA 10:0_FA 10:0WD 22:0/FA 10:0_FA 10:0WD 22:0;2O(FA 10:0),3O(FA 10:0)WD 22:0;2O(FA 10:0[S]),3O(FA 10:0[R])
N-acyl amines (NA)dNA 24:4NA 4:0/20:4NA 4:0/20:4(5,8,11,14)NA 4:0/20:4(5Z,8Z,11Z,14Z)NA 4:0/20:4(5Z,8Z,11Z,14Z)
N-acyl ethanolamines (NAE)dNAE 18:2NAE 18:2NAE 18:2(9,12)NAE 18:2(9Z,12Z)NAE 18:2(9Z,12Z), anandamide 18:2(n-6)
Fatty acyl estolides (FA-EST)FAHFA 36:1;OFAHFA 18:1/18:0;OFAHFA 18:1(9)/18:0;OFAHFA 18:1(9Z)/9O(FA 18:0)FAHFA 18:1(9Z)/9O(FA 18:0[R])

Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).

Shorthand notation applies only when exact location and nature of functional group(s) are determined by specific fragment ions obtained by derivatization and GC/MS or specific product ions in a MS/MS experiment.

Validated assay is required to employ trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic based separation of potential isomers (GC or HPLC).

In shorthand notation for wax monoesters (WE), wax diesters (WD), and fatty amides (NA, NAE), alcohol and amine moieties precede the fatty acyl moiety.

Level-dependent shorthand notation for examples of class="Chemical">fatty aldehydes, <class="Chemical">span class="Chemical">esters, and amides Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9). Shorthand notation applies only when exact location and nature of functional group(<span class="Chemical">s) are determined by class="Chemical">specific fragment ions obtained by derivatization and GC/MS or class="Chemical">specific product ions in a MS/MS experiment. Validated assay is required to employ <span class="Chemical">trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic <class="Chemical">span class="Chemical">based separation of potential isomers (GC or HPLC). In shorthand notation for wax monoclass="Chemical">esters (WE), <class="Chemical">span class="Chemical">wax diesters (WD), and fatty amides (NA, NAE), alcohol and amine moieties precede the fatty acyl moiety.

Oxygenated fatty acyls

class="Chemical">Lipidomic studies of “<class="Chemical">span class="Chemical">oxygenated fatty acyls,” commonly referred to as “oxylipins” or “oxygenated PUFAs” in the literature, involves analysis of enzymatically and nonenzymatically generated lipids such as octadecanoids, eicosanoids, docosanoids, do- and tetratriacontanoids (Table 2D–F). Enzymatically generated isomers include prostaglandins, leukotrienes, and the various “specialized pro-resolving mediators,” i.e., lipoxins, protectins, maresins, and resolvin D/Es (Table 2F) (16). Nonenzymatic oxygenation of polyunsaturated fatty acids leads to numerous cyclic structures with various stereochemistry, such as phytoprostanes, isoprostanes, neuroprostanes, and all families of furans. Some of these isoprostanoids were identified over 25 years ago, particularly those of mammalian origin (17) and more recently also as components in foods of plant origin (18). The nomenclature for isoprostanoids is based on Taber, Morrow, and Roberts (19) and Rokach et al. (20), an update appeared in 2010 (21). Table 2G presents the precursor-product relationships for the classes of phytoprostanes, isoprostanes, and neuroprostanes, for which abbreviations PhytoP, IsoP, and NeuroP, respectively, have been proposed.
TABLE 2F

Parent polyunsaturated fatty acids and oxygenated product specialized pro-resolving mediators

Fatty AcidProduct ClassComplete Structure Level (= Common Name)
Arachidonic acid; AA(n-6)EicosanoidLipoxin A4, lipoxin B4
Eicosapentaenoic acid; EPA(n-3)EicosanoidResolvin E1, E2, E3
Docosahexaenoic acid; DHA(n-3)DocosanoidResolvin D1, D2, D3, D4, D5, D6
Docosapentaenoic acid; DPA(n-3)DocosanoidResolvin T1, T2, T3, T4
Docosahexaenoic acid; DHA(n-3)DocosanoidPCTR1, PCTR2, PCTR3, protectin D1/neuroprotectin D1
Docosahexaenoic acid; DHA(n-3)DocosanoidMCTR1, 2, 3, maresins 1, 2
Docosahexaenoic acid; DHA(n-3)DocosanoidProtectin DX
Dotriacontahexaenoic acid; FA 32:6(n-3)DotriacontanoidElovanoid ELV-N32
Tetratriacontahexaenoic acid; FA 34:6(n-3)TetratriacontanoidElovanoid ELV-N34
TABLE 2G

Parent polyunsaturated fatty acids and oxygenated product isoprostanoids

Fatty AcidProduct ClassComplete Structure Level (= Common Name)
α-Linoleic acid; ALA(n-3)OctadecanoidF1-PhytoP
γ-Linolenic acid; GLA(n-6)OctadecanoidF1-PhytoPGLA
Arachidonic acid; AA(n-6)EicosanoidF2-IsoP
Eicosapentaenoic acid; EPA(n-3)EicosanoidF3-IsoP
Adrenic acid; AdA(n-6)DocosanoidF2-IsoPAdA
Docosapentaenoic acid; DPA(n-6)DocosanoidF3-NeuroPDPA(n-6)
Docosapentaenoic acid; DPA(n-3)DocosanoidF3-NeuroPDPA(n-3)
Docosahexaenoic acid; DHA(n-3)DocosanoidF4-NeuroP
FA 22:4(4Z,7Z,10Z,18E);[13-17cy5;14OH,16OH];20OH
Shorthand notations for a<span class="Chemical">cyclic oxylipins at appropriate levels of annotation in <class="Chemical">span class="Chemical">lipidomic studies Uncharged molecular mass measured by low resolution MS of corresponding m/z from <span class="Chemical">carboxylate anion (electroclass="Chemical">spray ionization) or molecular ion class="Chemical">species (radical cation by EI). Annotation <span class="Chemical">based on the assumption of a straight-chain fatty acyl plus functional groups <class="Chemical">span class="Chemical">based on exact mass measurements using a high-resolution mass spectrometer of fatty acyl indicating ion. Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9). Shorthand notation applies only when exact location and nature of functional group(<span class="Chemical">s) are determined by class="Chemical">specific fragment ions obtained by derivatization and GC/MS or class="Chemical">specific product ions in a MS/MS experiment. Common shorthand accepted by IUPAC (23). Validated assay is required to employ <span class="Chemical">trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic <class="Chemical">span class="Chemical">based separation of potential isomers (GC or HPLC). Shorthand notations for <span class="Chemical">cyclic oxylipins at appropriate levels of annotation in <class="Chemical">span class="Chemical">lipidomic studies Uncharged molecular mass measured by low resolution MS of corresponding m/z from <span class="Chemical">carboxylate anion (electroclass="Chemical">spray ionization) or molecular ion class="Chemical">species (radical cation by EI). Annotation <span class="Chemical">based on the assumption of a straight-chain fatty acyl plus functional groups <class="Chemical">span class="Chemical">based on exact mass measurements using a high-resolution mass spectrometer of fatty acyl indicating ion. Shorthand notation applies only when exact location and nature of functional group(<span class="Chemical">s) are determined by class="Chemical">specific fragment ions obtained by derivatization and GC/MS or class="Chemical">specific product ions in a MS/MS experiment. Common shorthand accepted by IUPAC (23). Validated assay is required to employ <span class="Chemical">trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic <class="Chemical">span class="Chemical">based separation of potential isomers (GC or HPLC). Parent <span class="Chemical">polyunsaturated fatty acids and <class="Chemical">span class="Chemical">oxygenated product specialized pro-resolving mediators Parent class="Chemical">polyunsaturated fatty acids and <class="Chemical">span class="Chemical">oxygenated product isoprostanoids Standards for structural validation by MS-inspection of these class="Chemical">oxygenated <class="Chemical">span class="Chemical">fatty acids are described by Galano et al. (17) and are in agreement with those referred to for oxylipins (22). Specific shorthand nomenclature has been previously suggested and widely used for polyunsaturated oxygenated fatty acids (23). The use of a common name (Table 2B, D, E) for <span class="Chemical">fatty acyls or in reporting <class="Chemical">span class="Chemical">lipidomic studies also requires a high level of validation, typically with a representative biological sample using, for example, stable isotope dilution and chiral LC-MS/MS or capillary GC/MS with highly reproducible retention times for authentic standards. Otherwise, assumptions made on the basis of biological intelligence must be clearly stated.
TABLE 2D

Shorthand notations for acyclic oxylipins at appropriate levels of annotation in lipidomic studies

Species Levela,bDB-Position LevelcStructure Defined LevelFull Structure LeveldComplete Structure Level (= Common Name)e,f
FA 18:2;OFA 18:2(9,11);OFA 18:2;OHFA 18:2(9Z,11E);13OH13R-HODE, 13S-HODE
FA 20:4;OFA 20:4(6,8,11,14);OFA 20:4;OHFA 20:4(6E,8Z,11Z,14Z);5OH5R-HETE, 5S-HETE
FA 20:4;OFA 20:4(5,8,10,14);OFA 20:4;OHFA 20:4(5Z,8Z,10E,14Z);12OH12R-HETE, 12S-HETE
FA 20:4;OFA 20:4(5,8,11,13);OFA 20:4;OHFA 20:4 (5Z,8Z,11Z,13E);15OH15R-HETE, 15S-HETE
FA 20:4;O2FA 20:4(6,8,10,14);O2FA 20:4;(OH)2FA 20:4(6Z,8E,10E,14Z);5OH,12OHLTB4 (5S,12R)
FA 20:5;O3FA 20:5(6,8,11,14,16);O3FA 20:5;OOH;OHFA 20:5(6E,8Z,11Z,14Z,16E);5OOH;18OH5S-Hp-18S-HEPE
FA 20:5;O3FA 20:5(6,8,10,14,16);O3FA 20:5;(OH)3FA 20:5(6Z,8E,10E,14Z,16E);5OH,12OH,18OHResolvin E1 (5S,12R,18R)
FA 22:6;O3FA 22:6(4,8,10,12,14,19);O3FA 22:6;(OH)3FA 22:6(4Z,8E,10Z,12E,14E,19Z);7OH,16OH,17OHResolvin D2 (7S,16R,17S)
FA 22:6;O2FA 22:6(4,8,10,12,16,19);O2FA 22:6;(OH)2FA 22:6(4Z,8E,10E,12E,16Z,19Z);7OH,14OHMaresin 1 (7R,14S)

Uncharged molecular mass measured by low resolution MS of corresponding m/z from carboxylate anion (electrospray ionization) or molecular ion species (radical cation by EI).

Annotation based on the assumption of a straight-chain fatty acyl plus functional groups based on exact mass measurements using a high-resolution mass spectrometer of fatty acyl indicating ion.

Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).

Shorthand notation applies only when exact location and nature of functional group(s) are determined by specific fragment ions obtained by derivatization and GC/MS or specific product ions in a MS/MS experiment.

Common shorthand accepted by IUPAC (23).

Validated assay is required to employ trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic based separation of potential isomers (GC or HPLC).

TABLE 2E

Shorthand notations for cyclic oxylipins at appropriate levels of annotation in lipidomic studies

Species Levela,bStructure Defined LevelFull Structure LevelcComplete Structure Level (= Common Name)d,e
FA 20:4;O3FA 20:3;(OH)2;oxoFA 20:2(5Z,13E);[8-12cy5;11OH;9oxo];15OHPGE2
FA 20:4;O3FA 20:3;(OH)2;oxoFA 20:2(5Z,13E);[8-12cy5;9OH;11oxo];15OHPGD2
FA 20:3;O3FA 20:3;(OH)3FA 20:2(5Z,13E);[8-12cy5;9OH,11OH];15OHPGF
FA 20:3;O3FA 20:2;(OH)2;oxoFA 20:1(13E);[8-12cy5;11OH;9oxo];15OH8-iso-PGE1
FA 20:3;O4FA 20:2;(OH)3;oxoFA 20:1(13E);[8-12cy5;9OH,11OH];15OH;6oxo6-oxo-PGF
FA 20:3;O4FA 20:3;(OH)3;oxyFA 20:2(5Z,13E);[8-13cy6;9OH,11OH);11oxy];15OHTXB2
FA 22:5;O3FA 22:5;(OH)3FA 22:4(4Z,7Z,10Z,18E);[13-17cy5;14OH,16OH];20OH20-F4-NeuroP

Uncharged molecular mass measured by low resolution MS of corresponding m/z from carboxylate anion (electrospray ionization) or molecular ion species (radical cation by EI).

Annotation based on the assumption of a straight-chain fatty acyl plus functional groups based on exact mass measurements using a high-resolution mass spectrometer of fatty acyl indicating ion.

Shorthand notation applies only when exact location and nature of functional group(s) are determined by specific fragment ions obtained by derivatization and GC/MS or specific product ions in a MS/MS experiment.

Common shorthand accepted by IUPAC (23).

Validated assay is required to employ trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic based separation of potential isomers (GC or HPLC).

GLYCEROLIPIDS (GL)

See and B for class abbreviations and examples, respectively. class="Chemical">Lipid class abbreviation followed by number of <class="Chemical">span class="Disease">C-atoms:number of DBE, for oxygenated lipids C-atoms:DBE;O-atoms, are as described in the Annotation of lipid structures section.
TABLE 3A

Class abbreviations in Category GL

Common NameLipid Class, LIPID MAPSAbbreviation
Monoacyl/alkylglycerides (monoglycerides)Monoradylglycerols [GL01]MG
Diacyl/alkylglycerides (diglycerides)Diradylglycerols [GL02]DG
Triacyl/alkylglycerides (triglycerides)Triradylglycerols [GL03]TG
EstolidesEstolides [GL0305]TG-EST
SulfoquinovosylmonoacylglycerolsGlycosylmonoacylglycerols [GL0401]SQMG
MonogalactosylmonoacylglycerolGlycosylmonoacylglycerols [GL0401]MGMG
DigalactosylmonoacylglycerolGlycosylmonoacylglycerols [GL0401]DGMG
SulfoquinovosyldiacylglycerolsGlycosyldiacylglycerols [GL0501]SQDG
MonogalactosyldiacylglycerolGlycosyldiacylglycerols [GL0501]MGDG
DigalactosyldiacylglycerolGlycosyldiacylglycerols [GL0501]DGDG
TABLE 3B

Examples for shorthand notation of glycerolipids

Bond TypeSpecies LevelaMolecular Species Levelbsn-Position LevelcFull Structure Leveld
AcylMG 18:0MG 18:0MG 0:0/18:0/0:0
AlkylMG O-18:0MG O-18:0MG 0:0/O-18:0/0:0
DiacylDG 34:1DG 16:0_18:1DG 16:0/18:1/0:0DG 16:0/18:1(9Z)/0:0
Acyl-alkylDG O-34:1DG O-16:0_18:1DG O-16:0/18:1/0:0DG O-16:0/18:1(9Z)/0:0
DialkylDG dO-32:1DG O-16:0_O-16:1DG O-16:0/O-16:1/0:0DG O-16:0/O-16:1(9Z)/0:0
DG 30:1e
TriacylTG 52:2TG 16:0_18:1_18:1TG 16:0/18:1/18:1TG 16:0/18:1(9Z)/18:1(11Z)
TG 16:0_36:2 (only one acyl chain identified)TG 16:0_18:1(sn-2)_18:1f
Acyl-alkylTG O-52:2TG O-16:0_18:1_18:1TG O-16:0/18:1/18:1TG O-16:0/18:1(9Z)/18:1(11Z)
TG 51:2e
Acyl-dialkylTG dO-52:2TG O-18:1_O-16:0_18:1TG O-18:1/O-16:0/18:1TG O-18:1(9Z)/O-16:0/18:1(9Z)
TG 50:2e
TrialkylTG tO-52:2TG O-18:1_O-16:0_O-18:1TG O-18:1/O-16:0/O-18:1TG O-18:1(9Z)/O-16:0/O-18:1(9Z)
TG 49:2e
TG-EstolideTG 68:3;O2TG 18:1_18:1_32:1;O2TG 16:0;O(FA 16:0)/18:1/18:1TG 16:0;5O(FA 16:0)/18:1(9Z)/18:1(9Z)

Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species.

Annotation requires MS/MS and detection of FA chain-specific fragments.

-Positions determined by specific analysis like differential mobility spectrometry (32), LC separation of isomeric species using silver ions (33).

DB-positions determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).

Annotation using low-resolution MS including the assumption of acyl chains only.

Only acyl-chain at sn-2-position is defined.

Class abbreviations in Category <span class="Chemical">GL Examples for shorthand notation of <span class="Chemical">glycerolipids Annotation <span class="Chemical">based on exact mass measurements using a high-resolution mass class="Chemical">spectrometer, which allows differentiation of iso<class="Chemical">span class="Chemical">baric acyl and alkyl species. Annotation requires MS/MS and detection of FA chain-specific fragments. -Positions determined by specific analysis like differential mobility spectrometry (32), LC separation of isomeric species using <span class="Chemical">silver ions (33). DB-positions determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9). Annotation using low-resolution MS including the assumption of acyl chains only. Only acyl-chain at <span class="Gene">sn-2-position is defined. <span class="Chemical">Glycerolipids with known fatty acyl/alkyl constituents (molecular class="Chemical">specie<class="Chemical">span class="Chemical">s): separator _: sn-position of acyl/alkyl constituents is not known. Constituents are presented in the order of increasing number of <span class="Disease">C-atoms, as are DB (<class="Chemical">span class="Chemical">DBE)-numbers for each C-atom number, e.g., TG 16:0_18:1_18:3. separator /: sn-position of acyl/alkyl constituents is proven (order <span class="Gene">sn-1/<class="Chemical">span class="Gene">sn-2/sn-3; no FA linked 0:0), e.g., TG 16:0/18:3/18:1. When only one acyl chain of TG is known, it is presented in front of the sum of the remaining two acyl residues, e.g., TG 16:0_36:3. When only one of the sn-positions is defined, this is indicated inside a pair of parentheses, e.g., TG 16:0_18:1(<span class="Gene">sn-2)_18:0. Other bond types than <span class="Chemical">ester bonds are indicated as follows in front of the sum of <class="Chemical">span class="Disease">C-atoms for acyl/alkyl constituents: O = alkyl, e.g., TG O-52:3 P = proven O-class="Gene">alk-1-enyl-bond (acid-sensitive <class="Chemical">span class="Chemical">ether bond in “neutral plasmalogens” is not counted as a DB/DBE within the acyl-chain), e.g., TG P-52:3 or at higher resolution TG P-16:0/18:3/18:1. More than one “non”-<span class="Chemical">ester bond is indicated in front of the bond type as d for di, t for <class="Chemical">span class="Chemical">tri, and e for tetra.

GLYCEROPHOSPHOLIPIDS (GP)

See for abbreviations and examples. Shorthand notation for class="Chemical">phospholipid class="Chemical">species contains abbreviation for <class="Chemical">span class="Chemical">phospholipid classes, followed by number of C-atoms:number of DBE, i.e., PS 36:4, for oxygenated lipids C-atoms:DBE;O-atoms, i.e., PS 36:3;O, as described in the Annotation of lipid structures section. Class abbreviations in Category <span class="Chemical">GP Examples for shorthand notation of class="Chemical">phospho- and <class="Chemical">span class="Chemical">lysophospholipids containing ester and/or ether bonds Annotation <span class="Chemical">based on exact mass measurements using a high-resolution mass class="Chemical">spectrometer, which allows differentiation of iso<class="Chemical">span class="Chemical">baric acyl and alkyl species. Annotation requires MS/MS and detection of FA chain specific fragments. sn-Positions determined by specific MS analysis like differential mobility spectrometry (34). Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9). Annotation using low resolution MS, QQQ and +PIS m/z 184 requires the assumption of even numbered <span class="Chemical">carbon chains only. Annotation using low resolution MS, QQQ and +NL 141 requires the assumption of even numbered <span class="Chemical">carbon chains only. Identification of plasmalogens (<span class="Gene">alk-1-enyl bond) require class="Chemical">specific MS analysis (35). Examples for shorthand notation of <span class="Chemical">phosphatidylinositol phosphates

Phospholipids (PLs) and Lysophospholipids (LPLs)

Molecular species of <span class="Chemical">phospholipids with known fatty acyl/alkyl constituents (Table 4B):
TABLE 4B

Examples for shorthand notation of phospho- and lysophospholipids containing ester and/or ether bonds

Bond TypeSpecies LevelaMolecular SPECIES Levelbsn-Position LevelcFull Structure Leveld
DiacylBMP 34:1BMP 16:0_18:1BMP 16:0/0:0/18:1/0:0 sn-2/sn-3/sn-2′/sn-3′BMP 16:0/0:0/18:1(9Z)/0:0 sn-2/sn-3/sn-2′/sn-3′
TetraacylCL 72:7CL 18:1_18:2_18:2_18:2CL 18:1/18:2/18:2/18:2 sn-1/sn-2/sn-1′/sn-2′CL 18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)18:2(9Z,12Z) sn-1/sn-2/sn-1′/sn-2′
CL 18:1_54:6 (only one acyl chain identified)
CL 36:3_36:4 (known DG fragments)
Tetra-alkylCL eO-80:0CL O-20:0/O-20:0/O-20:0/O-20:0CL O-20:0/O-20:0/O-20:0/O-20:0CL O-16:0(3Me,7Me,11Me,15Me)/O-16:0(3Me,7Me,11Me,15Me)/O-16:0(3Me,7Me,11Me,15Me)/O-16:0(3Me,7Me,11Me,15Me)
DiacylPC 34:1ePC 16:0_18:1PC 16:0/18:1PC 16:0/18:1(9Z)
AlkylPC O-34:1ePC O-16:0_18:1PC O-16:0/18:1PC O-16:0/18:1(9Z)
DialkylPC dO-34:1PC O-16:0_O-18:1PC O-16:0/O-18:1PC O-16:0/O-18:1(9Z)
DiacylPE 34:1fPE 16:0_18:1PE 16:0/18:1PE 16:0/18:1(9Z)
PlasmalogenPE O-34:2fPE P-16:0/18:1gPE P-16:0/18:1(9Z)
TriacylLCL 54:5LCL 18:1_18:2_18:2LCL 18:1/18:2/18:2/0:0LCL 18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/0:0
MonoacylLPC 16:0eLPC 16:0LPC 16:0/0:0LPC 16:0/0:0
MonoalkylLPC O-16:0eLPC O-16:0LPC O-16:0/0:0LPC O-16:0/0:0

Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species.

Annotation requires MS/MS and detection of FA chain specific fragments.

sn-Positions determined by specific MS analysis like differential mobility spectrometry (34).

Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).

Annotation using low resolution MS, QQQ and +PIS m/z 184 requires the assumption of even numbered carbon chains only.

Annotation using low resolution MS, QQQ and +NL 141 requires the assumption of even numbered carbon chains only.

Identification of plasmalogens (alk-1-enyl bond) require specific MS analysis (35).

separator _: sn-position of acyl/alkyl constituents is not known. Order of constituent presentation as described for <span class="Chemical">glycerolipids, e.g., PC 16:0_18:2. separator /: sn-position of acyl/alkyl constituents is proven (class="Gene">sn-1/<class="Chemical">span class="Gene">sn-2 or sn-2/sn-3); no constituent 0:0; e.g., PC 16:0/18:2. For BMP and CL classes sn-position order will be class="Gene">sn-2/sn-3/<class="Chemical">span class="Gene">sn-2′/sn-3′ and sn-1/sn-2/sn-1′/sn-2′, respectively. When only one acyl chain or DG moieties of CL are known, sum of acyl residues are presented, e.g., CL 16:0_54:3 and CL 34:1_36:2, respectively. <span class="Chemical">Lysophospholipid classes are abbreviated as stated in <class="Chemical">span class="Chemical">LIPID MAPS nomenclature (Table 4A). Molecular species with unknown sn-position are presented as, e.g., LPE 18:1, with known sn-position as LPE 18:1/0:0 (Table 4B).
TABLE 4A

Class abbreviations in Category GP

Common NameLipid Class, LIPID MAPSAbbreviation
Bis[monoacylglycero]phosphatesMonoacylglycerophosphomonoradylglycerols [GP0410]BMP
CardiolipinsGlycerophosphoglycerophosphoglycerols [GP12]CL
Phosphatidic acidsGlycerophosphates [GP10]PA
PhosphatidylcholinesGlycerophosphocholines [GP01]PC
PhosphatidylethanolaminesGlycerophosphoethanolamines [GP02]PE
PhosphatidylgylcerolsGlycerophosphoglycerols [GP04]PG
PhosphatidylgylcerolphosphatesGlycerophosphoglycerophosphates [GP05]PGP
PhosphatidylinositolsGlycerophosphoinositols [GP06]PI
PhosphatidylserinesGlycerophosphoserines [GP03]PS
LysophospholipidsPrefix L
Phosphatidylinositol-mannosidePIM
Subclasses phosphatidylinositol phosphates
 Phosphatidylinositol-monophosphatesGlycerophosphoinositol monophosphates [GP07]PIP
 Phosphatidylinositol-3-phosphatesGlycerophosphoinositol monophosphates [GP07]PIP(3′)
 Phosphatidylinositol-4-phosphatesGlycerophosphoinositol monophosphates [GP07]PIP(4′)
 Phosphatidylinositol-5-phosphatesGlycerophosphoinositol monophosphates [GP07]PIP(5′)
 Phosphatidylinositol-bisphosphatesGlycerophosphoinositol bisphosphates [GP08]PIP2
 Phosphatidylinositol-3,4-bisphosphatesGlycerophosphoinositol bisphosphates [GP08]PIP2(3′,4′)
 Phosphatidylinositol-3,5-bisphosphatesGlycerophosphoinositol bisphosphates [GP08]PIP2(3′,5′)
 Phosphatidylinositol-4,5-bisphosphatesGlycerophosphoinositol bisphosphates [GP08]PIP2(4′,5′)
 Phosphatidylinositol-trisphosphatesGlycerophosphoinositol trisphosphates [GP09]PIP3
N-modified phospholipids
N-alkyl PSPS-N(Alk)
N-acyl PSPS-N(FA)
 Phosphatidylserine-carboxyalkylpyrrolesPS-CAP
 Phosphatidylserine-malondialdehydesPS-MDA
N-alkyl PEPE-N(Alk)
N-acyl PEPE-N(FA)
 Phosphatidylethanolamine-carboxyalkylpyrrolesPE-CAP
 Phosphatidylethanolamine-glucosidesPE-Glc
 Phosphatidylethanolamine-glucuronidesPE-GlcA
 Phosphatidylethanolamine-α-ketoglucosidePE-GlcK
 Phosphatidylethanolamine-carboxymethylatesPE-CM
 Phosphatidylethanolamine-carboxyethylatesPE-CE
 Phosphatidylethanolamine-formamidesPE-FA
 Phosphatidylethanolamine-carbamidesPE-CA
 Phosphatidyethanolamine- malondialdehydesPE-MDA
 Phosphatidylethanolamine-hydroxynonenalsPE-HNE
 Phosphatidylethanolamine-isolevuglandinsPE-isoLG
Other bond types than class="Chemical">ester bonds are indicated as described for <class="Chemical">span class="Chemical">Glycerolipids, e.g., for an ether phospholipid PE O-18:0/18:2, for a “plasmalogen” PE P-18:0/20:4.

Phosphatidylinositol phosphates (PIPs)

It is described in the Annotation of class="Chemical">lipid structures section, when functional groups are part of <class="Chemical">span class="Chemical">lipid class abbreviation, their proven positions are shown directly at the abbreviation’s end inside parentheses, separated by a comma if more than one. A prominent example is PIP3(3′,4′,5′). Table 4C shows that “Phosphate position level” identifies phosphate position at inositol ring, i.e., PIP(3′) 38:4, otherwise it would be PIP 38:4. For ease of handling by databases, numbers of phosphates are not written in lower case.
TABLE 4C

Examples for shorthand notation of phosphatidylinositol phosphates

Bond TypeSpecies LevelPhosphate Position LevelMolecular Species Levelsn-Position LevelFull Structure Level
DiacylPIP 36:1PIP(3′) 36:1PIP(3′) 16:0_18:1PIP(3′) 16:0/18:1PIP(3′) 16:0/18:1(9Z)
DiacylPIP2 38:4PIP2(4′,5′) 38:4PIP2(4′,5′) 18:0_20:4PIP2(4′,5′) 18:0/20:4PIP2(4′,5′) 18:0/20:4(4Z,8Z,11Z,14Z)

N-modified phospholipids and lysophospholipids

The amino function in PSs and PEs, including their lysoforms, is prone to react with a variety of electrophiles as has been shown in recent years (24). The products are generally termed N-mod PL and N-mod class="Gene">LPL in abbreviated form, common names and reclass="Chemical">spective abbreviations are shown in Table 4A. Structures at <class="Chemical">span class="Chemical">Species-, Molecular species-, and sn-Position levels are presented in shorthand notation as described in the Annotation of lipid structures, Glycerolipids (GL), and Glycerophospholipids (GP) sections; specific examples are shown in Table 4D.
TABLE 4D

Examples for shorthand notation of N-modified phospholipids

Oxidative ModificationSpecies Level aMolecular Species Level bsn-Position Level cFull Structure Level
N-alkylPS-N(Alk) 40:3PS-N(6:0)16:0_18:3PS-N(6:0) 16:0/18:3PS-N(6:0) 16:0/18:3(9Z,12Z,15Z)
N-acylPE-N(FA) 54:5PE-N(FA 18:1) 16:0_20:4PE-N(FA 18:1) 16:0/20:4PE-N(FA 18:1(9Z)) 16:0/20:4(4Z,8Z,11Z,14Z)
Hydroxynonenal adductPE-HNE 36:4PE-HNE 16:0_20:4PE-HNE 16:0/20:4PE-HNE 16:0/20:4(4Z,8Z,11Z,14Z)

Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species.

Annotation requires MS/MS and detection of FA chain specific fragments.

sn-Positions determined by specific MS analysis like differential mobility spectrometry (34).

Examples for shorthand notation of <span class="Chemical">N-modified phospholipids Annotation <span class="Chemical">based on exact mass measurements using a high-resolution mass class="Chemical">spectrometer, which allows differentiation of iso<class="Chemical">span class="Chemical">baric acyl and alkyl species. Annotation requires MS/MS and detection of FA chain specific fragments. sn-Positions determined by specific MS analysis like differential mobility spectrometry (34).

OxPLs

class="Chemical">Phospholipids containing <class="Chemical">span class="Gene">PUFA-constituents having methylene-interrupted cis-DBs (allylic DBs) and/or polar headgroups having amino-residues are susceptible to oxidation with formation of OxPLs. OxPL, so far, is a general term for a class of lipids produced by several processes that most often cannot be distinguished by MS analysis of the products. In all these cases, the products are called OxPLs (25). Respective modes for production are the following: class="Chemical">Oxygenation of PL to produce <class="Chemical">span class="Chemical">OxPL by direct action of lipoxygenases on PUFA constituents of PL gives rise to enzymatically produced specific oxPL. The stereochemistry of the resulting PUFA component usually reflects the specificity of the specific enzyme involved (26). The Land’s cycle is an alternative mechanism for enzymatic class="Chemical">OxPL formation. Free, un<class="Chemical">span class="Chemical">esterified PUFAs liberated by phospholipase A2 and other enzymatic pathways from PL are first oxygenated by lipoxygenases, cyclooxygenases or CYP450 oxygenases. The resulting oxygenated PUFAs can then be reesterified into PLs resulting in the indirect enzymatic formation of specific oxPL. Nonenzymatic reactions are induced by free-radical class="Chemical">oxygen/<class="Chemical">span class="Chemical">nitrogen species reacting directly with the PUFA constituents of PL or with free PUFAs which become incorporated into the PL by acyl transferases producing nonenzymatically derived oxPL. This oxygen transfer to PUFAs can further lead to DB rearrangement, cyclization and even truncation of such acyl-chains resulting in complex mixtures of oxPL (27). Nonradical class="Chemical">reactive oxygen class="Chemical">species like <class="Chemical">span class="Chemical">singlet oxygen or ozone can also contribute to PL oxidation with generation of full-chain or fragmented oxPL. PL having a polar head group with a modified amino-function (PE and P<span class="Chemical">S) form a subclass named <class="Chemical">span class="Chemical">oxPL-Nmod. Shorthand notation for <span class="Chemical">OxPLs in general are presented in Table 4E.
Table 4E

Examples for shorthand notation of OxPLs

Oxidative ModificationSpecies LevelaMolecular Species Levelbsn-Position LevelcStructure Defined LevelFull Structure Level
HydroxylationPC 36:4;OPC 16:0_20:4;OPC 16:0/20:4;OPC 16:0/20:4;OHPC 16:0/20:4(5Z,8Z,10E,14Z);12OH
PC 34:1;O2PC 16:0_18:1;O2PC 16:0/18:1;O2PC 16:0/18:1;(OH)2PC 16:0/18:1(9Z);12OH,13OH
EpoxidePC 34:2;OPC 16:0_18:2;OPC 16:0/18:2;OPC 16:0/18:1;EpPC 16:0/18:1(9Z);12Ep
HydroperoxidePC 34:2;O2PC 16:0_18:2;O2PC 16:0/18:2;O2PC 16:0/18:2;OOHPC 16:0/18:2(9Z,11E);13OOH
PeroxidePC 34:2;O2PC 16:0_18:2;O2PC 16:0/18:2;O2PC 16:0/18:1;OOPC 16:0/18:1(9Z);12OO
AldehydePC 21:1;OPC 16:0_5:1;OPC 16:0/5:1;OPC 16:0/5:0;oxoPC 16:0/5:0;5oxo
Carboxylic acidPC 25:1;O2PC 16:0_9:1;O2PC 16:0/9:1;O2PC 16:0/9:0;COOHPC 16:0/9:0;8COOH
Hydroxy-aldehydePC 26:3;O2PC 18:1_8:2;O2PC 18:1/8:2;O2PC 18:1/8:1;OH;oxoPC 18:1(9Z)/8:1(6E);5OH;8oxo
PC sn-2 positionPC 36:4;O3PC 16:0_20:4;O3PC 16:0/20:4;O3PC 16:0/20:2;[cy5;OH;oxo];OHPC 16:0/20:2(5Z,13E);[8-12cy5;11OH;9oxo];15OH (common name 8-IsoPGE2-PC)

Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species.

Annotation requires MS/MS and detection of FA chain specific fragments.

sn-Positions determined by specific MS analysis like differential mobility spectrometry (34).

Examples for shorthand notation of <span class="Chemical">OxPLs Annotation <span class="Chemical">based on exact mass measurements using a high-resolution mass class="Chemical">spectrometer, which allows differentiation of iso<class="Chemical">span class="Chemical">baric acyl and alkyl species. Annotation requires MS/MS and detection of FA chain specific fragments. sn-Positions determined by specific MS analysis like differential mobility spectrometry (34).

SPHINGOLIPIDS (SP)

Apart from class="Chemical">sphingosine containing 18 <class="Chemical">span class="Disease">C-atoms with two hydroxyl groups and one DB, other sphingoid bases reveal prominent backbones as well, particularly in brain or nonmammalian specimens (28). Consequently, the abbreviation SPB is strongly recommended as shorthand notation for the general term “sphingoid bases,” Cer for ceramides, and SM for sphingomyelins (). Table 5B, C, and D define, in addition, shorthand notation according to structural resolution of sphingolipids. The updated rules for shorthand notation are the following:
TABLE 5A

Class abbreviations in Category SP

Common NameLipid Class, LIPID MAPSAbbreviation
Sphingoid basesSphingoid bases [SP01]SPB
Sphingoid base-phosphatesSphingoid bases [SP0105]SPBP
CeramidesCeramides [SP02]Cer
Ceramide-phosphatesCeramide phosphates [SP0205]CerP
Acyl CeramidesAcylceramides [SP0204]ACer
SphingomyelinsPhosphosphingolipids [SP03]SM
HexosylceramidesNeutral glycosphingolipids [SP05]HexCer
GlucosylceramideNeutral glycosphingolipids [SP05]GlcCer
GalactosylceramideNeutral glycosphingolipids [SP05]GalCer
DihexosylceramidesNeutral glycosphingolipids [SP05]Hex2Cer
LactosylceramideNeutral glycosphingolipids [SP05]LacCer
SulfatidesSulfoglycosphingolipids (sulfatides) [SP0602]SHexCer
InositolphosphorylceramidesCeramide phosphoinositols [SP0303]IPC (PI-Cer)
EthanolaminephosphorylceramidesCeramide phosphoethanolamines [SP0302]EPC (PE-Cer)
GlycosylinositolphosphorylceramidesCeramide phosphoinositols [SP0303]GIPC
Mannosyl-inositolphosphoceramidesCeramide phosphoinositols [SP0303]MIPC
Mannosyl-diinositolphosphoceramideCeramide phosphoinositols [SP0303]M(IP)2C
TABLE 5B

Examples for shorthand notation of sphingolipids with a free amino group

Sphingoid BaseSpecies LevelaStructure Defined LevelFull Structure Levelb
SphingosineSPB 18:1;O2SPB 18:1;(OH)2SPB 18:1(4E);1OH,3OH
3-Keto-sphinganineSPB 18:1;O2SPB 18:0;OH;oxoSPB 18:0;1OH;3oxo
SphinganineSPB 18:0;O2SPB 18:0;(OH)2SPB 18:0;1OH,3OH
SphingadieneSPB 18:2;O2SPB 18:2;(OH)2SPB 18:2(4E,14Z);1OH,3OH
PhytosphingosineSPB 18:0;O3SPB 18:0;(OH)3SPB 18:0;1OH,3OH,4OH
C20-sphingosineSPB 20:1;O2SPB 20:1;(OH)2SPB 20:1(4E);1OH,3OH
Sphingosine-1-phosphateSPBP 18:1;O2SPBP 18:1;OHSPBP(1) 18:1(4E);3OH
Sphinganine-1-phosphateSPBP 18:0;O2SPBP 18:0;OHSPBP(1) 18:0;3OH
1-Deoxymethyl-sphinganineSPB 17:0;OSPB 17:0;OHSPB 17:0;2OH
1-Deoxy-sphinganineSPB 18:0;OSPB 18:0;OHSPB 18:0;3OH
LysoinositolphosphorylceramidesLIPC 18:0;O3LIPC 18:0;(OH)2LIPC(1) 18:0;3OH,4OH
LysosphingomyelinLSM 18:1;O2LSM 18:1;OHLSM(1) 18:1(4E);3OH

Annotation based on exact mass measurements using a high-resolution mass spectrometer.

Positions of functional groups and DBs determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photochemical derivatization (9).

TABLE 5C

Examples for shorthand notation of sphingolipids containing an amide bound fatty acid

PhylaSpecies LevelaMolecular Species LevelbFull Structure Levelc
MammalianCer 34:1;O2Cer 18:1;O2/16:0Cer 18:1(4E);1OH,3OH/16:0
MammalianCer 34:0;O2Cer 18:0;O2/16:0Cer 18:0;1OH,3OH/16:0
MammalianACer 58:1;O2FA 24:1-ACer 18:1;O2/16:0FA 24:1-ACer(1) 18:1(4E);3OH/16:0
MammalianCerP 34:1;O2CerP 18:1;O2/16:0CerP(1) 18:1(4E);3OH/16:0
MammalianSM 36:2;O2dSM 18:2;O2/18:0SM(1) 18:2(4E,14Z);3OH/18:0
MammalianSM 44:2;O2dSM 20:1;O2/24:1SM(1) 20:1(4E);3OH/24:1(15Z)
MammalianCer 62:3;O4Cer 18:1;O2/26:0;O(FA 18:1)eCer 18:1(4E);1OH,3OH/26:0;26O(FA 18:1(9Z))
Cer 18:1;O2/44:2;O2f
PlantIPC 42:1;O4IPC 18:1;O3/24:0;OIPC(1) 18:1(8E);3OH,4OH/24:0;2OH
YeastCer 44:0;O5Cer 18:0;3O/26:0;O2Cer 18:0;1OH,3OH,4OH/26:0;2OH,3OH

Annotation based on exact mass measurements using a high-resolution mass spectrometer.

Annotation requires MS/MS enabling detection of sphingoid base and/or N-linked FA.

Positions of functional groups and DBs determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photochemical derivatization (9).

Annotation using low resolution MS QQQ and a PIS m/z 184 requires the assumption of a sphingoid base with two hydroxyl groups.

Annotation with structural characterization of O-acyl in N-linked acyl chain.

Annotation without structural differentiation of N-linked acyl chain.

TABLE 5D

Examples for shorthand notation of glycosphingolipids containing an amide bound fatty acid

PhylaSpecies LevelaMolecular Species LevelbFull Structure Levelc
MammalianHex-Cer 34:1;O2Hex-Cer 18:1;O2/16:0Glc-Cer(1) 18:1(4E);3OH/16:0 (see also Fig. 1)
Glc-Cer 18:1;O2/16:0 d
MammalianHex-Cer 34:0;O2Hex-Cer 18:0;O2/16:0Gal-Cer(1) 18:0;3OH/16:0
Gal-Cer 18:0;O2/16:0d
MammalianHex2Cer 34:1;O2Hex2Cer 18:1;O2/16:0Lac-Cer(1) 18:1(4E);3OH/16:0e
Gal-Glc-Cer(1) 18:1(4E);3OH/16:0
MammalianHex3Cer 42:1;O2Hex3Cer 18:1;O2/24:0Gal-Gal-Glc-Cer(1) 18:1(4E);3OH/24:0 (= Gb3)
MammalianNeuAcHex2Cer 42:1;O2NeuAcHex2Cer 18:1;O2/24:0NeuAc-Gal-Glc-Cer(1) 18:1(4E);3OH/24:0 (= GM3)
MammalianNeuAc2Hex2Cer 42:1;O2NeuAc2Hex2Cer 18:1;O2/24:0NeuAc-NeuAc-Gal-Glc-Cer(1) 18:1(4E);3OH/24:0 (= GD3)
MammalianSHex-Cer 34:1;O2SHex-Cer 18:1;O2/16:0S(3′)Hex-Cer(1) 18:1(4E);3OH/16:0
S(3′)Gal-Cer(1) 18:1(4E);3OH/16:0e
MammalianSHexHexNAcHex3Cer 34:1;O2SHexHexNAcHex3Cer 18:1;O2/16:0S(3′)Hex-HexNac-Hex-Hex-Hex-Cer(1) 18:1(4E);3OH/16:0
S(3′)Gal-GalNAc-Gal-Gal-Glc-Cer(1) 18:1(4E);3OH/16:0e (globopentaosylceramide sulfate)
PlantHexA-IPC 42:1;O4HexA-IPC 18:1;O3/24:0;OGlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH
PlantHexHexA-IPC 42:1;O4Hex-HexA-IPC 18:1;O3/24:0;OGlc-GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH
PlantHexAHexNAc-IPC 42:1;O4HexNAc-HexA-IPC 18:1;O3/24:0;OGlcNAc-GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH
PlantHexHexAHexNAc-IPC 42:1;O4Hex-HexNAc-HexA-IPC 18:1;O3/24:0;OGlc-GlcNAc-GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH
YeastMIPC 44:0;O4MIPC 18:0;O3/26:0;OMIPC(1) 18:0;3OH,4OH/26:0;2OH
YeastM(IP)2C 46:0;O4M(IP)2C 20:0;O3/26:0;OM(IP)2C(1) 20:0;3OH,4OH/26:0;2OH

Annotation based on exact mass measurements using a high-resolution mass spectrometer.

Annotation requires MS/MS enabling detection of sphingoid base and/or N-linked FA.

Positions of functional groups and DBs determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photochemical derivatization (9).

Separation of isomeric hexosylceramide by HILIC (36).

Annotation requires separation of stereoisomers at glycosidic linkage (α/β).

In case the long-chain class="Chemical">base is not known, the sum composition of <class="Chemical">span class="Chemical">sphingoid base and fatty acid is shown as number of C-atoms:DBE;O-atoms, e.g., SPB 34:1;O2. In class="Chemical">ceramides the class="Chemical">sphingoid <class="Chemical">span class="Chemical">backbone is annotated C-atoms:DBE;O-atoms separated by a slash from the number of C-atoms:DBE;O-atoms of the N-linked fatty acid, e.g., Cer 18:1;O2/16:0. DB geometry and positions of class="Chemical">hydroxyl groups (or other functional group<class="Chemical">span class="Chemical">s) are annotated as described for fatty-acyl-chains in Tab. 2B, e.g., Cer 18:1(4E);1OH,3OH/16:0.
TABLE 1B

Abbreviations of cyclic structures

Cyclic StructuresAbbreviation
Cyclopropylcy3
Cyclopropenylcy3:1
Cyclobutylcy4
Cyclopentylcy5
Cyclohexylcy6
When the number of class="Chemical">hydroxyl groups cannot be determined, numbers of <class="Chemical">span class="Disease">C-atoms and DBE are assigned under the assumption of the number of hydroxyl groups in the major sphingoid base for that organism (e.g., dihydroxy in mammals). For further characterization of class="Chemical">N-linked fatty acids, the rules as described in the Annotation of <class="Chemical">span class="Chemical">lipid structures section apply. The position of a fatty acid esterified to an N-linked hydroxy-fatty acyl is shown in a separate pair of parentheses xO(FA C-atoms:DBE) with x denoting the position of hydroxyl group (Δ nomenclature) in the N-linked fatty acids, e.g., Cer 18:1;O2/26:0;18O(FA 16:0). Any modification linked to a class="Chemical">sphingoid base-OH is written in front of the (sub)class abbreviation with the integrated position number in parenthesis at the end of abbreviation, e.g., FA 24:<class="Chemical">span class="Chemical">1-ACer (1) 18:1;3OH/16:0 for an acylceramide, Gal-Cer (1) 18:0;3OH/16:0 for a galactosylceramide. Consequently, in shorthand notation from “Structure defined level” onwards only unmodified OH-groups of the <span class="Chemical">sphingoid base are annotated. Shorthand notation for <span class="Chemical">carbohydrate moieties is stated in Table 1C and examples are shown in Table 5D.
TABLE 1A

Abbreviations of functional groups/side chains

Functional Group/Side ChainAbbreviation
Ethyl branchEt
Methyl branchMe
BromoBr
ChloroCl
FluoroF
IodoI
NitroNO2
EpoxyEp
PeroxyOO
MethoxyOMe
Alkoxy (ether)oxy
AminoNH2
HydroperoxyOOH
SulfanylSH
hydroxyOH
Oxo (keto/aldehyde; depending on position)oxo
CyanoCN
PhosphateP
SulfateS
Carboxylic acidCOOH
GlycineG
TaurineT

The order of functional groups aligns with IUPAC hierarchy (14).

For annotation of the class="Chemical">sugar moiety in complex <class="Chemical">span class="Chemical">glycosphingolipids we refer to current practice in glycan science (https://www.ncbi.nlm.nih.gov/glycans) (15). When the sequence of sugars components is known, they are shown in this order separated by a hyphen. In case the sequence is unknown the components (followed by their number if more than one) are shown in alphabetic order in front of the respective lipid backbone. Annotation of the ceramide part follows the rules described above. class="Chemical">Sphingoid base phosphates with unknown <class="Chemical">span class="Chemical">phosphate position are represented by SPBP, e.g., SPBP 18:1;(OH)2. class="Chemical">Sphingoid base phosphates with known position of <class="Chemical">span class="Chemical">phosphate and of OH-positions is annotated by, e.g., SPBP (1) 18:1(4E);3OH. class="Chemical">Ceramide phosphates with unknown <class="Chemical">span class="Chemical">phosphate position are represented by CerP, e.g., CerP 18:1;O2/16:0. class="Chemical">Ceramide phosphates with known position of <class="Chemical">span class="Chemical">phosphate and of OH-positions are annotated by, e.g., CerP (1) 18:1(4E);3OH. class="Chemical">Ceramide phosphates with <class="Chemical">span class="Chemical">1,3 cyclic phosphate and known OH-positions are annotated by, e.g., CerP (1, 3) 18:1(4E). Class abbreviations in Category SP Examples for shorthand notation of <span class="Chemical">sphingolipids with a free amino group Annotation <span class="Chemical">based on exact mass measurements using a high-resolution mass class="Chemical">spectrometer. Positions of functional groups and DBs determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photochemical derivatization (9). Examples for shorthand notation of class="Chemical">sphingolipids containing an <class="Chemical">span class="Chemical">amide bound fatty acid Annotation <span class="Chemical">based on exact mass measurements using a high-resolution mass class="Chemical">spectrometer. Annotation requires MS/MS enabling detection of <span class="Chemical">sphingoid base and/or <class="Chemical">span class="Chemical">N-linked FA. Positions of functional groups and DBs determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photochemical derivatization (9). Annotation using low resolution MS QQQ and a PIS m/z 184 requires the assumption of a <span class="Chemical">sphingoid base with two <class="Chemical">span class="Chemical">hydroxyl groups. Annotation with structural characterization of O-acyl in N-linked acyl chain. Annotation without structural differentiation of N-linked acyl chain. Examples for shorthand notation of class="Chemical">glycosphingolipids containing an <class="Chemical">span class="Chemical">amide bound fatty acid Annotation <span class="Chemical">based on exact mass measurements using a high-resolution mass class="Chemical">spectrometer. Annotation requires MS/MS enabling detection of <span class="Chemical">sphingoid base and/or <class="Chemical">span class="Chemical">N-linked FA. Positions of functional groups and DBs determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photochemical derivatization (9). Separation of isomeric <span class="Chemical">hexosylceramide by HILIC (36). Annotation requires separation of stereoisomers at <span class="Disease">glycosidic linkage (α/β).

STEROLS (ST)

We use the term class="Chemical">sterol to embrace all molecules <class="Chemical">span class="Chemical">based on the cyclopentanoperhydrophenanthrene skeleton. In the case of sterols, the ring system does not add to the number of DBE. Endogenously biosynthesized mammalian sterols are derived from cholesterol or its precursors, yet plant and yeast sterols can also be a source via the food chain. The stereochemistry of the cholesterol molecule is maintained to a large extent by mammalian sterols, which all contain at least one hydroxyl or oxo group attached to carbon 3. High resolution MS with accurate mass may identify other functional groups, as will MS/MS or MSn scans. Stereochemistry can often be defined by comparing the chromatographic retention time to authentic standards and, in some cases, by MS/MS or MSn. The class abbreviations within category ST are shown in .
TABLE 6A

Class abbreviations in Category ST

Common NameLipid Class, LIPID MAPSAbbreviation
SterolsSterols [ST01]ST
Sterol estersSterol esters [ST0102]SE
Bile acidsBile acids and derivatives [ST04]BA
Free cholesterol = cholesterolFC
Cholesteryl esterCholesteryl esters [ST0102]CE
SterylglycosidesSterylglycosidesSG
AcylsterylglycosidesMonoradylglycosterolsASG
Class abbreviations in Category ST The following rules for shorthand nomenclature have been adopted in the examples given in Table 6B.
TABLE 6B

Examples of shorthand notation for sterols

Lipid ClassSpecies LevelFull Structure LevelComplete Structure Level (= Common Name)
ST (FC)ST 27:1;OST 27:1(5Z);3bOH = FCCholesterol
STST 27:1;OST 27:1(7);5aH;3bOHLathosterol
STST 28:3;OST 28:3(5Z,7Z,22E);24Me[R];3bOHErgosterol
STST 27:2;O3ST 27:1(5Z);3bOH;26COOH[25R]3β-Hydroxycholest-5-en-(25R)26-oic acid
SESE 27:1/16:0CE 16:0Cholesteryl palmitate
SESE 27:1/18:2CE 18:2(9Z,12Z)Cholesteryl linoleate
SESE 27:2/18:1SE 27:2(8E,24);5aH/18:1(9Z)Zymosteryl oleate
STST 21:3;O2ST 21:1(4Z);3oxo,20oxoProgesterone
STST 19:2;O2ST 19:1(4Z);17bOH;3oxoTestosterone
STST 19:2;O2ST 19:1(5Z);3bOH;17oxoDehydroepiandrosterone
STST 18:3;O2ST 18:3(1,3,5);3OH,17bOH17β-Estradiol
STST 19:2;O2;SST 19:1(5Z);3bS;17oxoDehydroepiandrosterone sulfate
BAST 24:1;O5BA 24:0;5bH;3aOH,7aOH,12aOH;24COOHCholic acid (CA)
BAST 24:1;O3BA 24:0;5bH;3aOH;24COOHLithocholic acid (LCA)
BABA 24:1;O5;TBA 24:0;5bH;3aOH,7aOH,12aOH;24COTTaurocholic acid (TCA)
BABA 24:1;O4;GBA 24:0;5bH;3aOH,7aOH;24COGGlycochenodeoxycholic acid (GCDCA)
BAST 24:1;O4;HexNAcBA 24:0;5bH;3aOH,7bOGlcNAc;24COOHUrsodeoxycholic acid 7β-N-acetylglucosaminide (UDCA-GlcNac)
SGSG 27:1;O;HexSG 27:1(5Z);3bOGlcCholesteryl glucoside
ASGASG 29:2;O;Glc;FA20:3ASG 29:2(5Z,22E);24Et[S];3bOGlc;6O(FA 20:3)20:3(11Z,14Z,17Z)-Glc-stigmasterol
In shorthand notation the category abbreviation ST is used as class abbreviation. In some cases, other abbreviations e.g., FC, CE, class="Chemical">BA, SE, SG and <class="Chemical">span class="Chemical">ASG can be used. In all cases, class abbreviation is followed by number of carbon atoms:number of DB, and separated by semicolon is the number of oxygens, e.g., ST 27:1;O for cholesterol and lathosterol (also zymostenol), or ST 24:1;O5 for an oxidized sterol and for cholic acid and ursocholic acid. The latter is an important point: Some bile acids have an identical mass and molecular formula to oxidized sterols lacking a carboxylic acid group. This must be considered, when class abbreviation “BA” is used. Shorthand notation of further functional groups are written, separated by a semicolon, after the number of class="Chemical">oxygens, e.g., <class="Chemical">span class="Chemical">BA 24:1;O5;T for taurocholic acid (= common name, abbreviation TCA). Following the number of double bonds, proven position and stereochemistry is shown. R and S configurations are preferred for side-chain stereochemistry and are shown in square brackets. α (below ring/plane), written as a, and β (above ring/plane), written as b, are preferred for ring stereochemistry, e.g. 3aOH and class="Chemical">17bOH. Stereochemistry at C-5 introduced by reduction of the Δ5 bond is indicated by 5aH or 5bH. Replacing the number of <class="Chemical">span class="Chemical">oxygens, proven positions and stereochemistry of oxygen containing functional groups are shown. If such stereochemistry is known the common name of the compound can be used. The side-chain at <span class="Chemical">carbon-17 of the <class="Chemical">span class="Chemical">cyclopentanoperhydrophenanthrene skeleton always has b-stereochemistry (17b) and consequently is not presented in the shorthand annotation. For structures fully proven or class="Chemical">based on assumption by biological intelligence, such as e.g., <class="Chemical">span class="Chemical">cholesterol, cholesteryl esters, steryl esters, bile acids, sterylglycosides, and acylsterylglycosides abbreviations FC, CE, SE, BA, SG and ASG, respectively, can be used as shown in Table 6A. CE is followed by number of C-atoms:number of DBE of the fatty acid esterified to the hydroxyl group at position 3, e.g., CE 18:2 (Table 6B). Shorthand notation SE is used as above followed by slash (for monohydroxysterols) or underscore (for polyhydroxysterols) number of C-atoms:number DBE of the fatty acid esterified to the hydroxyl group (Table 6B). MS/MS scans reveal the presence of conjugates: class="Chemical">Taurine (T) and <class="Chemical">span class="Chemical">glycine (G) each are conjugated through an amide bond to the carboxylic acid group of bile acids, respective amide bonds with conjugates are designated in shorthand notation “COT” and “COG” (Table 6B); sulfuric acid (S) is conjugated to a hydroxyl group through an ester bond; glucuronic acid (GlcA), N-acetylglucosamine (GlcNAc), and hexose (Hex) sugars are assumed to be linked to a hydroxyl group through an acetal linkage (Table 6B). In the case full stereochemistry is known the common names as presented in Table 6B can be used. Examples of shorthand notation for <span class="Chemical">sterols

DISCUSSION AND CONCLUSIONS

This publication updates both the classification and nomenclature (2, 3) and shorthand notation (4), and targets two goals. First, to emphasize and enable correct reporting of mass spectromeclass="Chemical">tric data according to the resolving power of MS instrument platforms operating in high-resolution (and often high-throughput) mode. Second, to provide a comprehensible shorthand notation for the <class="Chemical">span class="Chemical">lipids commonly analyzed. Such common nomenclature is essential for standardized reporting of lipid species data and construction of data resources. Moreover, standardized data facilitate automated datamining and import into databases by script-based algorithms with only minimal data curation. Related data repositories require a hierarchical concept mirroring the structural resolution provided by mass spectrometric analysis reflected in the presented shorthand notation. To this end, the LMSD database, respective MS search tool, and, in particular, shorthand notations for all relevant lipids are now available on the LMSD detail view pages at “Species level” and “Molecular species level”, the latter embracing “Phosphate-”, “DB-”, and “sn-position level”. In a few instances, however, easy use of this shorthand notation by lipidomics experts has priority over its stringent use in a bioinformatics format. A standardized annotation for class="Chemical">lipid class="Chemical">species, as a common language, is a key component to promote and further advance this emerging omics discipline (29). Therefore, the <class="Chemical">span class="Chemical">Lipidomics Standards Initiative (LSI; https://lipidomics-standards-initiative.org/) has been recently introduced (13), pursuing development of guidelines and channeling community-wide efforts in close collaborations with LIPID MAPS (https://www.lipidmaps.org/) as has been emphasized recently (30). In addition, alignment with other initiatives, as for example, adaptation of mzTab-M, a data format developed for metabolomics (31), to the presented nomenclature is possible. In summary, the shorthand nomenclature presented here is viewed as a standard in <span class="Chemical">lipidomics that can be updated periodically.

Data availability

All data are contained within this article.
TABLE 1C

Abbreviations of carbohydrate structures

Carbohydrate StructuresAbbreviation
HexoseHex
GalactoseGal
GlucoseGlc
MannoseMan
Neuraminic acidNeu
N-acetyl hexosamineHexNAc
N-acetyl galactosamineGalNAc
N-acetyl glucosamineGlcNAc
N-acetyl neuraminic acidNeuAc
N-glycolylneuraminic acidNeuGc
Keto-deoxy-glycero-galacto-nononic acidKdn
Glucuronic acidGlcA
XyloseXyl
FucoseFuc

Glycan annotation is based on IUPAC-approved abbreviations (https://www.ncbi.nlm.nih.gov/glycans/snfg.html) (15).

  32 in total

1.  Nomenclature.

Authors:  W L Smith; P Borgeat; M Hamberg; L J Roberts; A l Willis; S Yamamoto; P W Ramwell; J Rokach; B Samuelsson; E J Corey
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  LIPID MAPS: Serving the next generation of lipid researchers with tools, resources, data, and training.

Authors:  Valerie B O'Donnell; Edward A Dennis; Michael J O Wakelam; Shankar Subramaniam
Journal:  Sci Signal       Date:  2019-01-08       Impact factor: 8.192

Review 3.  A comprehensive classification system for lipids.

Authors:  Eoin Fahy; Shankar Subramaniam; H Alex Brown; Christopher K Glass; Alfred H Merrill; Robert C Murphy; Christian R H Raetz; David W Russell; Yousuke Seyama; Walter Shaw; Takao Shimizu; Friedrich Spener; Gerrit van Meer; Michael S VanNieuwenhze; Stephen H White; Joseph L Witztum; Edward A Dennis
Journal:  J Lipid Res       Date:  2005-02-16       Impact factor: 5.922

Review 4.  Lipidomics: Current state of the art in a fast moving field.

Authors:  Valerie B O'Donnell; Kim Ekroos; Gerhard Liebisch; Michael Wakelam
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2019-10-23

5.  Nomenclature of isoprostanes: a proposal.

Authors:  J Rokach; S P Khanapure; S W Hwang; M Adiyaman; J A Lawson; G A FitzGerald
Journal:  Prostaglandins       Date:  1997-12

Review 6.  Update of the LIPID MAPS comprehensive classification system for lipids.

Authors:  Eoin Fahy; Shankar Subramaniam; Robert C Murphy; Masahiro Nishijima; Christian R H Raetz; Takao Shimizu; Friedrich Spener; Gerrit van Meer; Michael J O Wakelam; Edward A Dennis
Journal:  J Lipid Res       Date:  2008-12-19       Impact factor: 5.922

7.  Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids.

Authors:  Karin A Zemski Berry; Robert C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2004-10       Impact factor: 3.109

Review 8.  Generation and biological activities of oxidized phospholipids.

Authors:  Valery N Bochkov; Olga V Oskolkova; Konstantin G Birukov; Anna-Liisa Levonen; Christoph J Binder; Johannes Stöckl
Journal:  Antioxid Redox Signal       Date:  2010-04-15       Impact factor: 8.401

9.  Shorthand notation for lipid structures derived from mass spectrometry.

Authors:  Gerhard Liebisch; Juan Antonio Vizcaíno; Harald Köfeler; Martin Trötzmüller; William J Griffiths; Gerd Schmitz; Friedrich Spener; Michael J O Wakelam
Journal:  J Lipid Res       Date:  2013-04-02       Impact factor: 5.922

10.  mzTab-M: A Data Standard for Sharing Quantitative Results in Mass Spectrometry Metabolomics.

Authors:  Nils Hoffmann; Joel Rein; Timo Sachsenberg; Jürgen Hartler; Kenneth Haug; Gerhard Mayer; Oliver Alka; Saravanan Dayalan; Jake T M Pearce; Philippe Rocca-Serra; Da Qi; Martin Eisenacher; Yasset Perez-Riverol; Juan Antonio Vizcaíno; Reza M Salek; Steffen Neumann; Andrew R Jones
Journal:  Anal Chem       Date:  2019-02-13       Impact factor: 6.986

View more
  74 in total

1.  Combining Micropunch Histology and Multidimensional Lipidomic Measurements for In-Depth Tissue Mapping.

Authors:  Melanie T Odenkirk; Brian M Horman; James N Dodds; Heather B Patisaul; Erin S Baker
Journal:  ACS Meas Sci Au       Date:  2021-10-28

Review 2.  Tracing Lipid Metabolism by Alkyne Lipids and Mass Spectrometry: The State of the Art.

Authors:  Lars Kuerschner; Christoph Thiele
Journal:  Front Mol Biosci       Date:  2022-05-20

3.  Retention dependences support highly confident identification of lipid species in human plasma by reversed-phase UHPLC/MS.

Authors:  Zuzana Vaňková; Ondřej Peterka; Michaela Chocholoušková; Denise Wolrab; Robert Jirásko; Michal Holčapek
Journal:  Anal Bioanal Chem       Date:  2021-07-09       Impact factor: 4.142

4.  Application of Lipid Class Ratios for Sample Stability Monitoring-Evaluation of Murine Tissue Homogenates and SDS as a Stabilizer.

Authors:  Sabrina Krautbauer; Raquel Blazquez; Gerhard Liebisch; Marcus Hoering; Philip Neubert; Tobias Pukrop; Ralph Burkhardt; Alexander Sigruener
Journal:  Metabolites       Date:  2021-04-27

Review 5.  Interpreting the lipidome: bioinformatic approaches to embrace the complexity.

Authors:  Jennifer E Kyle; Lucila Aimo; Alan J Bridge; Geremy Clair; Maria Fedorova; J Bernd Helms; Martijn R Molenaar; Zhixu Ni; Matej Orešič; Denise Slenter; Egon Willighagen; Bobbie-Jo M Webb-Robertson
Journal:  Metabolomics       Date:  2021-06-06       Impact factor: 4.290

6.  Yeast-based reference materials for quantitative metabolomics.

Authors:  Hendri Wasito; Gerrit Hermann; Veronika Fitz; Christina Troyer; Stephan Hann; Gunda Koellensperger
Journal:  Anal Bioanal Chem       Date:  2021-10-13       Impact factor: 4.478

7.  Fatty Acid Unsaturation Degree of Plasma Exosomes in Colorectal Cancer Patients: A Promising Biomarker.

Authors:  Joan Bestard-Escalas; Rebeca Reigada; José Reyes; Paloma de la Torre; Gerhard Liebisch; Gwendolyn Barceló-Coblijn
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

8.  Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells.

Authors:  Claudia Di Carlo; Bebiana C Sousa; Marcello Manfredi; Jessica Brandi; Elisa Dalla Pozza; Emilio Marengo; Marta Palmieri; Ilaria Dando; Michael J O Wakelam; Andrea F Lopez-Clavijo; Daniela Cecconi
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

Review 9.  Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?

Authors:  Ariel Frajerman; Linda Scoriels; Oussama Kebir; Boris Chaumette
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

10.  Accurate Lipid Quantification of Tissue Homogenates Requires Suitable Sample Concentration, Solvent Composition, and Homogenization Procedure-A Case Study in Murine Liver.

Authors:  Marcus Höring; Sabrina Krautbauer; Louisa Hiltl; Verena Babl; Alexander Sigruener; Ralph Burkhardt; Gerhard Liebisch
Journal:  Metabolites       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.